A 45-year-old woman with severe ARDS on VV-ECMO develops new left-sided consolidation with air bronchograms on CXR. She is receiving 'rest settings' on the ventilator: PCV, Pinsp 10 cmH2O, PEEP 10 cmH2O, FiO2 0.3, RR 10/min. Tracheal aspirate grows Pseudomonas aeruginosa. When dosing antibiotics for a patient on ECMO, what pharmacokinetic consideration is most important?